XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 4,036,267 $ 11,149,136 $ 18,806,667 $ 35,175,531
General and administrative 6,291,079 11,859,702 19,960,421 29,639,951
Total operating expenses 10,327,346 23,008,838 38,767,088 64,815,482
Loss from operations (10,327,346) (23,008,838) (38,767,088) (64,815,482)
Other (expenses) income:        
Interest/investment income, net 247,013 856,478 1,008,758 2,875,379
Realized (loss) gain on short-term investments (81,438) 147,835 28,717 334,082
Unrealized gain on short-term investments 70,275 278,555 212,210 283,803
Total other (expense) income – net 235,850 1,282,868 1,249,685 3,493,264
Net loss $ (10,091,496) $ (21,725,970) $ (37,517,403) $ (61,322,218)
Loss per common share – basic (in Dollars per share) $ (0.3) $ (0.72) $ (1.16) $ (2.03)
Loss per common share – diluted (in Dollars per share) $ (0.3) $ (0.72) $ (1.16) $ (2.03)
Weighted average number of common shares outstanding – basic (in Shares) 33,191,622 30,174,202 32,274,238 30,160,242
Weighted average number of common shares outstanding – diluted (in Shares) 33,191,622 30,174,202 32,274,238 30,160,242